CClinicalTrials.gg
TerminatedNCT04931927Updated Jul 28, 2022

Impact of Telehealth on Engagement in Psychotherapy and/or Medication Treatment

An interventional study of Making Connections Intervention-Telehealth (MCI-T) and Treatment as usual (TAU) in Psychiatric Diagnosis, sponsored by New York State Psychiatric Institute. Terminated at 1 site in United States. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-07-28.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Treatment

Why this study was terminated
This study has been terminated due to a change in study design. The study is no longer a RCT.
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

In the present study, investigators aim to (1) adapt the Making Connections Intervention (MCI) as an intervention to address telehealth engagement and examine whether this targeted intervention can improve youth engagement in telehealth treatment; and (2) assess attitudes towards help-seeking and therapeutic alliance from both the youth and clinician viewpoint to examine the impact of these factors on engagement in telemental health treatment. Forty adolescent participants ages 12-18 will be randomized to either telehealth treatment as usual (TAU) plus the telehealth Making Connections Intervention (MCI-T) engagement session or telehealth TAU alone and followed for 12 weeks from baseline assessment. All clinicians will receive training in the MCI-T intervention and provide either MCI-T + usual care or usual care only depending on the condition to which the adolescents are randomized. All evaluations and therapy sessions will be done over telehealth platform.

Read the detailed description

Clinicians who participate in the study may be assigned more than one study case, and therefore will complete measures on each study case. All of the clinicians will receive training in the Making Connections Intervention-Telehealth (MCI-T) intervention. The clinicians will deliver the intervention based on the random assignment of the adolescent participants to a treatment arm. When clinicians provide care to adolescents randomized to the MCI-T condition, they will participate in a monthly consultation over telehealth to review cases to promote adherence and fidelity to the treatment.

02

Conditions studied

  • Psychiatric Diagnosis

Browse trials for

Keywords

  • anxiety
  • depression
  • telehealth
  • behavioral problems
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's enrollment of 14 is below the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 425 studies on the registry; 26 are open to participants now.

Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Youth Sample

  1. Youth ages 12-18 years of age receiving an evaluation in the diagnostic evaluation service, the Diagnostic Evaluation and Stabilization Clinic (DESC), or another clinical service in the outpatient Child Behavioral Health Service at NewYork Presbyterian (NYP) - Morgan Stanley Children's Hospital (MSCH)/ NYP-MSCH.
  2. English speaking

Exclusion Criteria: Youth Sample

  1. Active Suicidal Ideation with current plan and/or intent that requires a higher level of care than outpatient treatment or treatment in DESC
  2. Diagnosis of intellectual disability

Inclusion Criteria: Clinician Sample

  1. Work as a clinician in any MSCH Outpatient Behavioral Health Service or DESC
  2. Clinician consent
  3. English or bilingual in English and Spanish

Exclusion Criteria: Clinician Sample

  1. None
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Active comparator
    Control

    Participants are randomized to treatment as usual (TAU)

    Behavioral: Treatment as usual (TAU)

  • Experimental
    MCI-T

    Participants are randomized to the Making Connections Intervention-Telehealth (MCI-T) plus treatment as usual (TAU)

    Behavioral: Making Connections Intervention-Telehealth (MCI-T) · Behavioral: Treatment as usual (TAU)

Interventions

  • BehavioralMaking Connections Intervention-Telehealth (MCI-T)

    Single session telehealth engagement intervention plus telehealth treatment as usual (TAU) \[MCI-T +TAU\]

  • BehavioralTreatment as usual (TAU)

    Telehealth treatment as usual without the single session telehealth engagement intervention

06

What researchers measure

Primary outcomes

  1. Change in the Working Alliance Inventory (WAI-S)

    The Working Alliance Inventory (WAI-S) reported by both teen and clinician is a self-report measure used to assess three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond. Items are rated on a 7-point scale ranging from 1 (never) to 7 (always) for the extent to which each of the given statements describes the youth's experience. A total alliance rating is calculated by summing the ratings of all 12 items and ranges from 12-84, with higher scores reflecting a more positive rating of working alliance. The WAI-S will be used to assess changes in working alliance between participants and clinicians through study completion at the 12-week follow-up assessment. The scale will be completed at week 1 about the prior 1 week, at week 6 about the prior 5 weeks, and at week 12 about the prior 6 weeks (post intervention).

    Time frame: week 1, week 6, week 12 (post intervention)

  2. Change in Barriers for Adolescent Seeking Health (BASH)

    The Barriers for Adolescent Seeking Health (BASH) is a 37-item scale that measures adolescents' barriers to seeking help from mental health professionals. Items are rated on a 3-point scale ranging from 1 (not at all) to 3 (a great deal) for the extent to which and individual experiences help-seeking barriers. A total score is calculated by summing the ratings of all 37 items and ranges from 37-111, with higher scores indicating greater barriers to seeking help from a mental health professional. The BASH will be used to assess changes in adolescents' barriers to seeking help from mental health professionals through study completion at the 12-week follow-up assessment. The scale will be completed at baseline about prior lifetime experiences, at week 6 about the prior 6 weeks, and at week 12 about the prior 6 weeks (post intervention).

    Time frame: baseline, week 6, week 12 (post intervention)

  3. Change in Attitudes toward Psychological Help-Seeking Scale (ATPHS)

    The Attitudes toward Psychological Help-seeking Scale (ATPHS) is a 5-item scale that assesses stigma in relation to seeking help for psychological problems. Items are rated on a 4-point scale ranging from 0 (strongly disagree) to 3 (strongly agree) for the extent to which an individual . A total score is calculated by summing the ratings of all 5 items and ranges from 0-20, with higher scores indicating more negative attitudes toward seeking psychological help. The ATPHS will be used to assess changes in youth's attitudes toward seeking psychological help through study completion at 12 week follow-up. The scale will be completed at baseline about the participan's lifetime, at week 6 about the prior 6 weeks, and at week 12 about the prior 6 weeks (post intervention).

    Time frame: baseline, week 6, week 12

Secondary outcomes

  1. Change in Progress of Treatment (POT)

    The Progress of Treatment Questionnaire (POT) is a 5-item questionnaire that assesses patient progress throughout treatment. Items are rated on a 5-point scale ranging from 1 (not at all) to 5 (very much) for the extent to which the clinician observes patient progress. A total score is calculated by summing the ratings of all 5 items and ranges from 5-25, with higher scores indicating greater patient progress. The POT will be used to assess changes in participants' progress of treatment through the study completion at the 12-week follow-up assessment. The questionnaire will be completed at week 6 about the prior 6 weeks, and at week 12 about the prior 6 weeks.

    Time frame: week 6, week 12

  2. Change in Client Satisfaction (CSQ-8)

    The Client Satisfaction (CSQ-8) is an 8-item self-report questionnaire that measures client satisfaction with psychological services. Items are rated on various different Likert scales as well as through open-ended questions for the extent to which an individual is satisfied with the psychological services they are receiving. A total score is calculated by summing the ratings of all 8 items and accounting for open-ended responses, with higher scores indicating greater client satisfaction. The CSQ-8 will be used to assess changes in participants' satisfaction with the psychological services they are receiving through the study completion at the 12-week follow-up assessment. The questionnaire will be completed at week 6 about the prior 6 weeks, and at week 12 about the prior 6 weeks.

    Time frame: week 6, week 12

07

Study locations

1 site
  • New York State Psychiatric Institute
    New York, New York 10032, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04931927
Lead sponsor
New York State Psychiatric Institute
Responsible party
Laura Mufson (Professor of Medical Psychology (in Psychiatry), New York State Psychiatric Institute) — Principal investigator
First posted
Jun 18, 2021
Start date
Nov 8, 2021
Primary completion
Jul 12, 2022
Completion
Jul 12, 2022
Last update
Jul 28, 2022

Study contacts

Laura Mufson, Ph.D.
principal investigator · Columbia University/NYSPI

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion